2CT7-2-EtO
Pharmaceutical compound
From Wikipedia, the free encyclopedia
2CT7-2-EtO, also known as 4-propylthio-2-ethoxy-5-methoxyphenethylamine, is a psychedelic drug of the phenethylamine, 2C, and TWEETIO families related to 2C-T-7.[1][2][3] It is the derivative of 2C-T-7 in which the methoxy group at the 2 position has been replaced with an ethoxy group.[1][2][3]
- None
| |
| Clinical data | |
|---|---|
| Other names | 2CT7-2EtO; 2CT7-2-ETO; 2CT7-2ETO; 4-Propylthio-2-ethoxy-5-methoxyphenethylamine; 2-Ethoxy-4-propylthio-5-methoxyphenethylamine |
| Routes of administration | Oral[1][2] |
| Drug class | Serotonergic psychedelic; Hallucinogen |
| ATC code |
|
| Pharmacokinetic data | |
| Onset of action | "Quick" or "fast"[1][2][3] |
| Duration of action | ~5 hours[1][2][3] |
| Identifiers | |
| |
| Chemical and physical data | |
| Formula | C14H23NO2S |
| Molar mass | 269.40 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
According to Alexander Shulgin in his book PiHKAL (Phenethylamines I Have Known and Loved) and other publications, 2CT7-2-EtO's dose is 20 mg orally and its duration is about 5 hours.[1][2][3] It was said to have a "quick" or "fast" onset and to be very short-lived.[1][2][3] The effects of 2CT7-2-EtO have been reported to include modest but real closed-eye visuals.[1] In addition, it was said to cause an uncomfortable headache the next day that intuitively seemed to be an after-effect of the drug.[1]
The chemical synthesis of 2CT7-2-EtO has been described.[1]
2CT7-2-EtO was first described in the literature by Shulgin in PiHKAL in 1991.[1] It was developed and tested by Darrell Lemaire, with publication via personal communication with Shulgin.[2][4][5][6][7] The drug is a controlled substance in Canada under phenethylamine blanket-ban language.[8]